Investment Thesis
GoodRx exhibits concerning fundamental weakness with flat revenue growth (0.6% YoY), anemic profitability (0.6% net margin), and critically, interest coverage of only 0.5x—meaning operating income fails to cover debt service obligations. While the company maintains adequate liquidity and positive free cash flow, the combination of minimal growth, razor-thin returns (ROE 0.2%), and high leverage relative to profitability creates an unsustainable financial structure.
Strengths
- Strong cash position of $235.7M provides liquidity buffer and financial flexibility
- Healthy liquidity ratios (1.47x current and quick ratios) reduce near-term solvency risk
- Positive free cash flow generation of $10.7M demonstrates operational cash generation capability
Risks
- CRITICAL: Interest coverage ratio of 0.5x indicates operating income cannot cover debt service—operationally unsustainable leverage structure
- Revenue growth essentially flat at 0.6% YoY with net margin of only 0.6%—company shows no growth momentum and barely profitable
- Extremely poor capital efficiency with ROE of 0.2% and ROA of 0.1%—shareholder capital is not generating meaningful returns
- High debt burden of $482.4M against minimal profitability creates refinancing and covenant risk if operational performance deteriorates
Key Metrics to Watch
- Interest coverage ratio—must move above 1.0x to reach operational sustainability
- Revenue growth rate and net margin trajectory—need to demonstrate acceleration or expansion
- Operating cash flow to interest expense ratio—monitor ability to service debt organically
- Debt reduction and leverage ratio—track progress on deleveraging given weak profitability
Financial Metrics
Revenue
194.0M
Net Income
1.2M
EPS (Diluted)
$0.00
Free Cash Flow
10.7M
Total Assets
2.0B
Cash
235.7M
Profitability Ratios
Gross Margin
N/A
Operating Margin
7.2%
Net Margin
0.6%
ROE
0.2%
ROA
0.1%
FCF Margin
5.5%
Balance Sheet & Liquidity
Current Ratio
1.47x
Quick Ratio
1.47x
Debt/Equity
0.78x
Debt/Assets
69.2%
Interest Coverage
0.48x
Long-term Debt
482.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T10:22:00.938782 |
Data as of: 2026-03-31 |
Powered by Claude AI